Expert guides, hospital insights, and medical travel tips for your China health journey
Tenofovir alafenamide (TAF, Vemlidy) costs USD 1,400+ per month in the US. In China, the same molecule from licensed hospital pharmacies costs USD 15–30. Here is the full clinical context.
Beijing and Shanghai are the default for international medical tourism in China, but Chengdu, Hangzhou, Nanjing and Wuhan offer Class A care at lower cost. Here are the trade-offs that matter clinically.
Coronary artery calcium (CAC) scoring is one of the highest-value cardiac imaging tests for primary prevention. In China, it's also one of the cheapest — by an order of magnitude.
China's egg freezing rules for international patients differ meaningfully from those for citizens. Here is what the actual workflow looks like, including age criteria, costs, and shipping logistics.
Stem cell injections are widely advertised — and frequently oversold. The honest evidence base for knee osteoarthritis is meaningful but specific. Here is what the data actually says.
China visa policies for international patients have evolved meaningfully over 2024–2026. Here is the practical, current state — including invitation letter logistics, length of stay, and family member coverage.
The most important quality signal in medical tourism is rarely the hospital itself — it's whether the coordinator is hospital-based or chain-clinic-based. Here is why this distinction matters more than most patients realise.
China has approved four major domestic PD-1 inhibitors with strong clinical evidence in multiple tumour types. The cost gap with Keytruda is enormous — but so are the indication differences. Here is the careful comparison.
A line-by-line breakdown of what a typical pre-treatment endocrinology workup at a Class A international department actually includes — and why this matters for GLP-1, thyroid, and metabolic patients.
Obstructive sleep apnoea is undertreated in most countries because the diagnostic gateway — polysomnography — is expensive and slow. China changes that math.
China has emerged as a global leader in CAR-T cell therapy delivery and clinical research. Here is the current state — approved indications, leading centres, costs, and the realistic outcomes data.
Bariatric surgery in China has matured rapidly. Here is the comparative landscape across the three main procedures, what they cost, and how outcomes compare to international benchmarks.
PandaTouring Care Newsletter
Research-backed guides on stem cell therapy, hospital quality data, and medical travel — delivered weekly.
No spam, ever. Unsubscribe anytime.
